Results | Latest & Breaking News on Results | Photos, Videos, Breaking Stories and Articles on Results

you are here: Home News

Divi’s Laboratories shares rally 6% on strong Q4 show; should you buy, sell or hold?
Divi's Labs' better-than-expected Q4 results trigger slew of price target upgrades
Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix
Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix
Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery
Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill
Divi’s Lab Q3FY23 preview: Consolidated net profit to likely drop 44% YoY
Divi's Q1 Poll| Solid profit, revenue growth on cards, but costs could dent margin
Divis Lab Q1 PAT seen up 27.3% YoY to Rs 709 cr: ICICI Direct
Divis Laboratories Q1 PAT seen up 12.5% YoY to Rs 626.8 cr: Prabhudas Lilladher
Divis Laboratories Q3 PAT seen up 42.7% YoY to Rs 671.7 cr: Prabhudas Lilladher
Divi’s Lab Q1 PAT seen up 8.4% YoY to Rs 533.6 cr: ICICI Direct
Divis Q4 PAT seen up 41.1% YoY to Rs. 467.2 cr: Sharekhan
Divi’s Q2 PAT may dip 9% YoY to Rs. 363.7 cr: Emkay
Divis Q3 PAT seen up 53.5% YoY to Rs. 370 cr: Sharekhan
Divi’s lab Q3 PAT seen up 82.3% YoY to Rs. 409.6 cr: ICICI Direct
India Inc Q2 review: Earnings breadth deteriorates; margin pressure stark
Divis Labs Q2 PAT seen up 45.7% YoY to Rs. 290 cr: HDFC Securities
Divis Q2 PAT seen up 39.2% YoY to Rs. 272.5 cr: Sharekhan
Divi’s Lab Q2 PAT seen up 33% YoY to Rs. 275.1 cr: ICICI Direct
Divi’s Lab Q4 PAT may dip 2.6% YoY to Rs. 280 cr: HDFC Securities
Divis Labs Q2 profit seen down 1% on lower operational income and revenue
Divis Q3 net likely up 11%, margins may be at 37%
Divis Labs Q1 profit seen up 9%; revenue & EBITDA may jump 17%
Divis Labs Q1 PAT seen down by 19.5% at Rs 259.3 cr: Religare

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Divi’s Laboratories shares rally 6% on strong Q4 show; should you buy, sell or hold?

Divi's Labs' better-than-expected Q4 results trigger slew of price target upgrades

Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix

Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix

Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery

Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill

Divi’s Lab Q3FY23 preview: Consolidated net profit to likely drop 44% YoY

Divi's Q1 Poll| Solid profit, revenue growth on cards, but costs could dent margin

Divis Lab Q1 PAT seen up 27.3% YoY to Rs 709 cr: ICICI Direct

Divis Laboratories Q1 PAT seen up 12.5% YoY to Rs 626.8 cr: Prabhudas Lilladher

Divis Laboratories Q3 PAT seen up 42.7% YoY to Rs 671.7 cr: Prabhudas Lilladher

Divi’s Lab Q1 PAT seen up 8.4% YoY to Rs 533.6 cr: ICICI Direct

Divis Q4 PAT seen up 41.1% YoY to Rs. 467.2 cr: Sharekhan

Divi’s Q2 PAT may dip 9% YoY to Rs. 363.7 cr: Emkay

Divis Q3 PAT seen up 53.5% YoY to Rs. 370 cr: Sharekhan

Divi’s lab Q3 PAT seen up 82.3% YoY to Rs. 409.6 cr: ICICI Direct

India Inc Q2 review: Earnings breadth deteriorates; margin pressure stark

Divis Labs Q2 PAT seen up 45.7% YoY to Rs. 290 cr: HDFC Securities

Divis Q2 PAT seen up 39.2% YoY to Rs. 272.5 cr: Sharekhan

Divi’s Lab Q2 PAT seen up 33% YoY to Rs. 275.1 cr: ICICI Direct

Divi’s Lab Q4 PAT may dip 2.6% YoY to Rs. 280 cr: HDFC Securities

Divis Labs Q2 profit seen down 1% on lower operational income and revenue

Divis Q3 net likely up 11%, margins may be at 37%

Divis Labs Q1 profit seen up 9%; revenue & EBITDA may jump 17%

Divis Labs Q1 PAT seen down by 19.5% at Rs 259.3 cr: Religare